ZimVie Inc. (ZIMV)
- Previous Close
16.98 - Open
17.14 - Bid 16.97 x 200
- Ask 17.04 x 200
- Day's Range
16.83 - 17.24 - 52 Week Range
6.52 - 20.91 - Volume
230,363 - Avg. Volume
334,307 - Market Cap (intraday)
464.454M - Beta (5Y Monthly) 2.00
- PE Ratio (TTM)
-- - EPS (TTM)
-1.92 - Earnings Date Jul 31, 2024 - Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
18.00
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
www.zimvie.comRecent News: ZIMV
Performance Overview: ZIMV
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZIMV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZIMV
Valuation Measures
Market Cap
464.45M
Enterprise Value
943.49M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.00
Price/Book (mrq)
1.20
Enterprise Value/Revenue
2.07
Enterprise Value/EBITDA
13.47
Financial Highlights
Profitability and Income Statement
Profit Margin
-81.52%
Return on Assets (ttm)
-0.30%
Return on Equity (ttm)
-9.04%
Revenue (ttm)
455.22M
Net Income Avi to Common (ttm)
-51.16M
Diluted EPS (ttm)
-1.92
Balance Sheet and Cash Flow
Total Cash (mrq)
43.53M
Total Debt/Equity (mrq)
134.57%
Levered Free Cash Flow (ttm)
12.29M
Research Analysis: ZIMV
Company Insights: ZIMV
ZIMV does not have Company Insights